Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Kinetics of antibody responses dictate COVID-19 outcome

View ORCID ProfileCarolina Lucas, Jon Klein, Maria Sundaram, Feimei Liu, Patrick Wong, View ORCID ProfileJulio Silva, View ORCID ProfileTianyang Mao, View ORCID ProfileJi Eun Oh, View ORCID ProfileMaria Tokuyama, View ORCID ProfilePeiwen Lu, Arvind Venkataraman, View ORCID ProfileAnnsea Park, Benjamin Israelow, Anne L. Wyllie, View ORCID ProfileChantal B. F. Vogels, M. Catherine Muenker, View ORCID ProfileArnau Casanovas-Massana, Wade L. Schulz, Joseph Zell, Melissa Campbell, John B. Fournier, Yale IMPACT Research Team, Nathan D. Grubaugh, Shelli Farhadian, Adam V. Wisnewski, Charles Dela Cruz, Saad Omer, Albert I. Ko, Aaron Ring, View ORCID ProfileAkiko Iwasaki
doi: https://doi.org/10.1101/2020.12.18.20248331
Carolina Lucas
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carolina Lucas
Jon Klein
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Sundaram
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feimei Liu
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Wong
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julio Silva
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julio Silva
Tianyang Mao
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tianyang Mao
Ji Eun Oh
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ji Eun Oh
Maria Tokuyama
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Tokuyama
Peiwen Lu
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peiwen Lu
Arvind Venkataraman
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annsea Park
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annsea Park
Benjamin Israelow
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne L. Wyllie
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal B. F. Vogels
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chantal B. F. Vogels
M. Catherine Muenker
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arnau Casanovas-Massana
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arnau Casanovas-Massana
Wade L. Schulz
4Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
5Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Zell
6Department of Internal Medicine/Section General Medicine; Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Campbell
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John B. Fournier
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan D. Grubaugh
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelli Farhadian
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam V. Wisnewski
6Department of Internal Medicine/Section General Medicine; Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Dela Cruz
7Department of Medicine, Section of Pulmonary and Critical Care Medicine; Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saad Omer
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
8Yale Institute for Global Health, Yale University, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert I. Ko
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
3Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Ring
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Iwasaki
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
9Howard Hughes Medical Institute, Chevy Chase, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Akiko Iwasaki
  • For correspondence: akiko.iwasaki{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Summary

Recent studies have provided insights into innate and adaptive immune dynamics in coronavirus disease 2019 (COVID-19). Yet, the exact feature of antibody responses that governs COVID-19 disease outcomes remain unclear. Here, we analysed humoral immune responses in 209 asymptomatic, mild, moderate and severe COVID-19 patients over time to probe the nature of antibody responses in disease severity and mortality. We observed a correlation between anti-Spike (S) IgG levels, length of hospitalization and clinical parameters associated with worse clinical progression. While high anti-S IgG levels correlated with worse disease severity, such correlation was time-dependent. Deceased patients did not have higher overall humoral response than live discharged patients. However, they mounted a robust, yet delayed response, measured by anti-S, anti-RBD IgG, and neutralizing antibody (NAb) levels, compared to survivors. Delayed seroconversion kinetics correlated with impaired viral control in deceased patients. Finally, while sera from 89% of patients displayed some neutralization capacity during their disease course, NAb generation prior to 14 days of disease onset emerged as a key factor for recovery. These data indicate that COVID-19 mortality does not correlate with the cross-sectional antiviral antibody levels per se, but rather with the delayed kinetics of NAb production.

Competing Interest Statement

A.I. received sponsored research funding from Spring Discovery, and served as an expert panel in Adaptive Biotechnologies discussion.

Funding Statement

This work was supported by the Womens Health Research at Yale Pilot Project Program (A.I.) [Fast Grant from Emergent Ventures at the Mercatus Center, Mathers Foundation, and the Ludwig Family Foundation, the Department of Internal Medicine at the Yale School of Medicine, Yale School of Public Health and the Beatrice Kleinberg Neuwirth Fund. IMPACT received support from the Yale COVID-19 Research Resource Fund. A.I. is an Investigator of the Howard Hughes Medical Institute. C.L. is a Pew Latin American Fellow. P.Y is supported by Gruber Foundation and the NSF. B.I. is supported by NIAID 2T32AI007517-16. C.B.F.V. is supported by NWO Rubicon 019.181EN.004.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics statement This study was approved by Yale Human Research Protection Program Institutional Review Boards (FWA00002571, protocol ID 2000027690). Informed consent was obtained from all enrolled patients and healthcare workers.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* A list of members and their affiliations appears at the end of the paper.

  • ↵† Lead contact: A.I. e-mail: akiko.iwasaki{at}yale.edu

Data Availability

All the background information on HCWs, clinical information for patients, and raw data used in this study are included in a Supplementary Table 1. Additionally all of the raw fcs files for the flow cytometry analysis are available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted December 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Kinetics of antibody responses dictate COVID-19 outcome
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Kinetics of antibody responses dictate COVID-19 outcome
Carolina Lucas, Jon Klein, Maria Sundaram, Feimei Liu, Patrick Wong, Julio Silva, Tianyang Mao, Ji Eun Oh, Maria Tokuyama, Peiwen Lu, Arvind Venkataraman, Annsea Park, Benjamin Israelow, Anne L. Wyllie, Chantal B. F. Vogels, M. Catherine Muenker, Arnau Casanovas-Massana, Wade L. Schulz, Joseph Zell, Melissa Campbell, John B. Fournier, Yale IMPACT Research Team, Nathan D. Grubaugh, Shelli Farhadian, Adam V. Wisnewski, Charles Dela Cruz, Saad Omer, Albert I. Ko, Aaron Ring, Akiko Iwasaki
medRxiv 2020.12.18.20248331; doi: https://doi.org/10.1101/2020.12.18.20248331
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Kinetics of antibody responses dictate COVID-19 outcome
Carolina Lucas, Jon Klein, Maria Sundaram, Feimei Liu, Patrick Wong, Julio Silva, Tianyang Mao, Ji Eun Oh, Maria Tokuyama, Peiwen Lu, Arvind Venkataraman, Annsea Park, Benjamin Israelow, Anne L. Wyllie, Chantal B. F. Vogels, M. Catherine Muenker, Arnau Casanovas-Massana, Wade L. Schulz, Joseph Zell, Melissa Campbell, John B. Fournier, Yale IMPACT Research Team, Nathan D. Grubaugh, Shelli Farhadian, Adam V. Wisnewski, Charles Dela Cruz, Saad Omer, Albert I. Ko, Aaron Ring, Akiko Iwasaki
medRxiv 2020.12.18.20248331; doi: https://doi.org/10.1101/2020.12.18.20248331

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3297)
  • Dentistry and Oral Medicine (364)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13381)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5155)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3271)
  • Health Policy (1142)
  • Health Systems and Quality Improvement (1192)
  • Hematology (432)
  • HIV/AIDS (1018)
  • Infectious Diseases (except HIV/AIDS) (14632)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (524)
  • Neurology (4928)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (726)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4216)
  • Public and Global Health (7507)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1014)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)